Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis.
OBJECTIVE
Recently, we have shown that shear stress regulates the angiogenic potential of endothelial cells in vitro by an Angiopoietin-2 (Ang2)-dependent mechanism; however its pathophysiological significance in vivo was not clear. We hypothesized that Ang2 plays an important role in blood flow recovery after arterial occlusion in vivo by regulating angiogenesis and arteriogenesis.


RESULTS
C57Bl/6J mice underwent femoral artery ligation and were injected with a specific Ang2 inhibitor, L1-10, or vehicle for 10 days. Ang2 mRNA was upregulated at day 2, and Ang2 protein was upregulated at day 2, 5, and 7 in the ligated hindlimb. L1-10 treatment significantly blunted blood flow recovery. L1-10 decreased smooth muscle cell coverage of neovessels without affecting capillary density, suggesting a specific role for Ang2 in arteriogenesis. Mechanistically, L1-10 decreased expression of intercellular and vascular cell adhesion molecules as well as infiltrating monocytes/macrophages in the ischemic tissue. Although L1-10 had no effect on the number of CD11b+ cells (monocytes/macrophages) mobilized in the bone marrow, it maintained elevated numbers of circulating CD11b+ cells in the peripheral blood.


CONCLUSIONS
These results suggest that Ang2 induced in ischemic tissue plays a critical role in blood flow recovery by stimulating inflammation and arteriogenesis.
Tressel
Sarah L
SL
Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, GA 30322, USA.
Kim
Hyongbum
H
Ni
Chih-Wen
CW
Chang
Kyunghwa
K
Velasquez-Castano
Juan C
JC
Taylor
W Robert
WR
Yoon
Young-Sup
YS
Jo
Hanjoong
H
D042683:Angiopoietin-1 / Q000378:metabolism; D042702:Angiopoietin-2 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D039481:CD11b Antigen / Q000097:blood; D002478:Cells, Cultured; D003097:Collateral Circulation; D004195:Disease Models, Animal; D042783:Endothelial Cells / Q000187:drug effects / Q000378:metabolism*; D005263:Femoral Artery / Q000601:surgery; D006801:Humans; D007249:Inflammation / Q000378:metabolism* / Q000503:physiopathology; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D007511:Ischemia / Q000209:etiology / Q000378:metabolism* / Q000503:physiopathology; D008026:Ligation; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018482:Muscle, Skeletal / Q000098:blood supply*; D018919:Neovascularization, Physiologic / Q000187:drug effects; D012333:RNA, Messenger / Q000378:metabolism; D042787:Receptor, TIE-2 / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000494:pharmacology; D012039:Regional Blood Flow; D013997:Time Factors; D015854:Up-Regulation; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism
D042683:Angiopoietin-1; D042702:Angiopoietin-2; D039481:CD11b Antigen; D012333:RNA, Messenger; D011993:Recombinant Fusion Proteins; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1; D042787:Receptor, TIE-2
Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):511-8
14726409
J Clin Invest. 1998 Jan 1;101(1):40-50
9421464
Cardiovasc Res. 2006 Dec 1;72(3):394-402
17054925
Nat Med. 2006 Feb;12(2):235-9
16462802
Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):290-5
18006856
Cancer Cell. 2004 Nov;6(5):507-16
15542434
Am J Pathol. 2000 Nov;157(5):1473-83
11073808
Oncogene. 2000 Sep 14;19(39):4549-52
11002428
Am J Pathol. 2000 Jun;156(6):2077-89
10854229
Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2150-6
17673702
Angiogenesis. 2001;4(4):247-57
12197469
Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H352-8
12649074
Nat Med. 2000 Apr;6(4):389-95
10742145
Science. 1997 Jul 4;277(5322):55-60
9204896
J Immunol. 2007 Jun 1;178(11):7405-11
17513791
Cell Tissue Res. 2007 May;328(2):329-37
17235601
Circ Res. 2004 Mar 19;94(5):671-7
14963007
Circ Res. 2007 Jul 6;101(1):88-96
17540977
N Engl J Med. 1999 Jan 14;340(2):115-26
9887164
J Pharmacol Exp Ther. 2005 Aug;314(2):738-44
15870388
J Mol Cell Cardiol. 2002 Jul;34(7):775-87
12099717
Circ Res. 1997 Oct;81(4):567-74
9314838
Curr Mol Med. 2006 Aug;6(5):457-77
16918368
Dev Cell. 2002 Sep;3(3):411-23
12361603
Circ Res. 2003 Apr 4;92(6):630-6
12609966